von Willebrand factor (vWF) is a central protein in blood coagulation. It serves as the carrier in plasma for factor VIII and as a major adhesive link between platelets and the blood vessel wall at sites of vascular injury. Abnormalities in vWF result in von Willebrand disease (vWD), the most common inherited bleeding disorder in humans. During the initial finding period for this project, we have made considerable progress toward understanding the molecular basis of vWD and the structure and function of vWF. Four point mutations, accounting for approximately 90% of type IIB vWD, have been identified within a 35 amino acid segment of the vWF A2 domain. A panel of seven mutations within the vWF Al domain similarly accounts for the majority of type IIA vWD patients. Transfection analysis of the latter mutations has identified two functional subgroups of type IIA vWD, associated with distinct molecular mechanisms. Structure/function studies, along with analysis of a new class of vWD patient mutations, has begun to define the critical region of vWF responsible for interaction with factor VIII. Comparative DNA and platelet RNA polymorphism analysis has been applied to the study of type I and type III vWD. Initial observations suggest that distinct molecular mechanisms may be responsible for these two disorders. Preliminary molecular genetic studies of type I vWD in the RIIIS/J mouse suggest that this animal model may be due to a defect at a novel genetic locus, distinct from the vWF gene.
The specific aims of the current proposal will extend our previous observations, with particular emphasis on the molecular basis of type I and type Ill vWD. Additional vWD patients will be studied to assemble diagnostically useful mutation screening panels and to further correlate genotype with phenotype. Additional vWF structure/function studies will further define the vWF binding domains for factor VIII and specific vWF receptors on the platelet surface and the blood vessel wall. Genetic linkage studies will address the questions of locus heterogeneity and potential modifying genetic factors in human vWD. In addition, positional cloning methods will be employed to identify the novel type I vWD gene in the RIIIS/J mouse. Taken together, the results of these studies should advance our understanding of vWD pathogenesis and should also provide new tools for the diagnosis and classification of this common disorder. In addition, these studies may lead to the development of new therapeutic approaches for the treatment of vWD as well as other genetic and acquired thrombotic and hemorrhagic disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039693-10
Application #
2714005
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1988-12-01
Project End
1999-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Nie, Chao; Wang, Huimin; Wang, Rui et al. (2018) Dimeric sorting code for concentrative cargo selection by the COPII coat. Proc Natl Acad Sci U S A 115:E3155-E3162
Khoriaty, Rami; Hesketh, Geoffrey G; Bernard, Amélie et al. (2018) Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci U S A 115:E7748-E7757
van Rooij, Frank J A; Qayyum, Rehan; Smith, Albert V et al. (2017) Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis. Am J Hum Genet 100:51-63
Khoriaty, Rami; Vogel, Nancy; Hoenerhoff, Mark J et al. (2017) SEC23B is required for pancreatic acinar cell function in adult mice. Mol Biol Cell 28:2146-2154
Khoriaty, Rami; Everett, Lesley; Chase, Jennifer et al. (2016) Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice. Sci Rep 6:27802
Ozel, A B; McGee, B; Siemieniak, D et al. (2016) Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance. J Thromb Haemost 14:1888-98
Emmer, Brian T; Ginsburg, David; Desch, Karl C (2016) Von Willebrand Factor and ADAMTS13: Too Much or Too Little of a Good Thing? Arterioscler Thromb Vasc Biol 36:2281-2282
Machiela, Mitchell J; Zhou, Weiyin; Sampson, Joshua N et al. (2015) Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet 96:487-97
Desch, Karl C (2015) Dissecting the genetic determinants of hemostasis and thrombosis. Curr Opin Hematol 22:428-36
Desch, Karl C; Kretz, Colin; Yee, Andrew et al. (2015) Probing ADAMTS13 substrate specificity using phage display. PLoS One 10:e0122931

Showing the most recent 10 out of 65 publications